Steven Liberty, senior vice president of operations for Patheon's
North American businesses spoke at Interphex on the strategies
contract manufacturing organisations (CMOs) can use to obtain a
Pharmaceutical manufacturers, distributors and retailers alike have
welcomed a unanimous vote by the California State Board of Pharmacy
to delay for another two years the implementation of electronic
pedigree requirements for tracking...
The globalisation of the supply chain increasingly challenges the
US Food and Drug Administration's ability to ensure the quality of
pharmaceuticals on the US market, acknowledges the acting director
of the agency's Center...
US contract manufacturer Catalent Pharma Solutions has leveraged
its partnership with Secure Symbology (SSI) for track and trace
barcode technology to help biopharmaceutical company Biogen Idec
comply with California's pending...
The first steps in tightening the safety controls on the
pharmaceutical ingredients imported to the US from China have been
taken following months of negotiations between the regulatory
bodies of the two countries.
Recipharm has come to rescue of UK-based Ashton Pharma, which has
been nervously awaiting to discover its fate, having spent five
months in administration after its former owners Inyx Inc. suffered
major financial woes.
GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made
further moves in their plans to boost their presence in Singapore,
a region growing in popularity for biopharmaceutical research and
The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
The burgeoning Japanese pharmaceutical market is set to boost the
third party logistics (3PL) sector as drug makers are expected to
increase their reliance on outsourcing for this type of services in
the future, a new report said.
Shipping giant DHL has bagged a lucrative contract with pharma
giant Wyeth and become the first logistics provider to be given
complete responsibility for a company's worldwide clinical trial
A number of executives and technical staff at small to medium size
pharmaceutical firms are unaware of how to use their resources
effectively to comply with new EMEA guidelines, designed to
minimise the environmental impact of compounds,...
Pharmaceutical companies are beginning to catch up with other
industry sectors that take an increasingly realistic view of what
they consider a core competency and outsourcing what is left -
Outsourcing-Pharma takes a snapshot of...
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
The market for radiofrequency identification (RFID) tags in
healthcare is set to explode from $90m (€70m) in 2006 to $2.1bn in
2016, driven by the item level tagging of drugs and the growing
appeal of "smart packaging."
Jacobs Engineering Group has inked a new contract with Boehringer
Ingelheim to provide technical and construction services for its
new bulk active pharmaceutical ingredient (API) facility being
built in Petersburg, Virginia, US.
Europe's third party logistics providers (3PL) are evolving to
integrate more of their operations with those of their clients in a
bid to provide a more efficient service, leaving the old breed in
danger of becoming extinct.
Nomeco, Denmark's biggest pharma wholesaler, has won a large
pre-wholesaling and logistics contract with Iceland's Actavis
covering the Nordic countries, typifying the regional shift in this
evolving sector of pharmaceutical...
Pharmaceutical wholesalers in Europe need to evolve to meet the
changing pharma market and a world of opportunity awaits for those
willing to think beyond their traditional business model and move
to compete in the outsourcing arena.